Risk of recurrent Helicobacter pylori infection 1 year after initial eradication therapy in 7 Latin American communities (Q36972107)

17 August 2017

Risk of recurrent Helicobacter pylori infection 1 year after initial eradication therapy in 7 Latin American communities (English)

1 reference

eradication of infectious diseases

17 August 2017

0 references

1 reference

Helicobacter pylori infectious disease

inferred from title

1 reference

Garnet L Anderson

18

0 references

Luis E. Bravo

object named as

Luis Eduardo Bravo

7

0 references

Catterina Ferreccio

9

object named as

Catterina Ferreccio

1 reference

17 August 2017

Douglas R Morgan

1

1 reference

17 August 2017

Javier Torres

2

1 reference

17 August 2017

Rachael Sexton

3

1 reference

17 August 2017

Rolando Herrero

4

1 reference

17 August 2017

Eduardo Salazar-Martínez

5

1 reference

17 August 2017

E Robert Greenberg

6

1 reference

17 August 2017

Ricardo L Dominguez

8

1 reference

17 August 2017

Eduardo C Lazcano-Ponce

10

1 reference

17 August 2017

Maria Mercedes Meza-Montenegro

11

1 reference

17 August 2017

Edgar M Peña

12

1 reference

17 August 2017

Rodolfo Peña

13

1 reference

17 August 2017

Pelayo Correa

14

1 reference

17 August 2017

María Elena Martínez

15

1 reference

17 August 2017

William D Chey

16

1 reference

17 August 2017

Manuel Valdivieso

17

1 reference

17 August 2017

Gary E Goodman

19

1 reference

17 August 2017

John J Crowley

20

1 reference

17 August 2017

Laurence H Baker

21

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 February 2013

1 reference

17 August 2017

9

1 reference

The Journal of the American Medical Association

inferred from page(s)

published in

1 reference

17 August 2017

309

1 reference

17 August 2017

6

1 reference

17 August 2017

578-586

1 reference

Global burden of cancers attributable to infections in 2008: a review and synthetic analysis

17 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3697935

Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3697935

Fifteen-year effects of Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3697935

14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trial

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3697935

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3697935

Sequential therapy or triple therapy for Helicobacter pylori infection: systematic review and meta-analysis of randomized controlled trials in adults and children

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3697935

Empiric quadruple vs. triple therapy for primary treatment of Helicobacter pylori infection: Systematic review and meta-analysis of efficacy and tolerability

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3697935

Meta-analysis: can Helicobacter pylori eradication treatment reduce the risk for gastric cancer?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3697935

Meta-analysis: four-drug, three-antibiotic, non-bismuth-containing "concomitant therapy" versus triple therapy for Helicobacter pylori eradication

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3697935

Exploring the cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer in China in anticipation of clinical trial results

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3697935

Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3697935

American College of Gastroenterology guideline on the management of Helicobacter pylori infection

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3697935

Projections of global mortality and burden of disease from 2002 to 2030

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3697935

Functional gastroduodenal disorders

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3697935

The recurrence of Helicobacter pylori infection: incidence and variables influencing it. A critical review.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3697935

Long term follow up of patients treated for Helicobacter pylori infection.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3697935

Helicobacter pylori reinfection is common in Peruvian adults after antibiotic eradication therapy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3697935

What is the Helicobacter pylori global reinfection rate?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3697935

The cost-effectiveness of population Helicobacter pylori screening and treatment: a Markov model using economic data from a randomized controlled trial

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3697935

Bacterial resistance to antimicrobial agents in Latin America. The giant is awakening

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3697935

Socioeconomic and behavioral factors leading to acquired bacterial resistance to antibiotics in developing countries

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3697935

Review article: Medical decision models of Helicobacter pylori therapy to prevent gastric cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3697935

Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trials

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3697935

Helicobacter pylori reinfection in Brazilian patients with peptic ulcer disease: a 5-year follow-up

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3697935

The time to eradicate gastric cancer is now

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3697935

Helicobacter pylori infection in children: relation with current household living conditions

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3697935

Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3697935

Helicobacter pylori recurrence in developed and developing countries: meta-analysis of 13C-urea breath test follow-up after eradication

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3697935

Cost-effectiveness analysis between primary and secondary preventive strategies for gastric cancer.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3697935

Long-term follow-up of 13C-urea breath test results after Helicobacter pylori eradication: frequency and significance of borderline delta13CO2 values

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3697935

Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3697935

High rates of recurrence and of transient reinfections of Helicobacter pylori in a population with high prevalence of infection

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3697935

Validation of a serologic test for the diagnosis of Helicobacter pylori infection and the immune response to urease and CagA in children

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3697935

Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-helicobacter pylori therapy

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3697935

The long-term reinfection rate and the course of duodenal ulcer disease after eradication of Helicobacter pylori in a developing country

20 October 2018

1 reference

12 December 2020

Clostridium difficile colitis associated with treatment of Helicobacter pylori infection

1 reference

12 December 2020

Clinical and economic effects of population-based Helicobacter pylori screening to prevent gastric cancer

1 reference

12 December 2020

High rate of Helicobacter pylori reinfection in children and adolescents

1 reference

12 December 2020

Comparison of time trends in stomach cancer incidence (1973-1997) in East Asia, Europe and USA, from Cancer Incidence in Five Continents Vol. IV-VIII

1 reference

12 December 2020

Garlic, vitamin, and antibiotic treatment for Helicobacter pylori: a randomized factorial controlled trial

1 reference

12 December 2020

Identifiers

DOI

10.1001/JAMA.2013.311

1 reference

17 August 2017

1 reference

17 August 2017

PubMed publication ID

23403682

1 reference